We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

CTNM

3.66000 USD
0.09
2.52%
Last update May 30, 3:59 PM EDT
Pre-market
Day range
3.42500
3.68500
Previous close
3.57000
Open
3.57000
Access this stock data via API
Subscribe
Continua Therapeutics Inc.
3.66
0.09
2.52%

Overview

Description

Continua Therapeutics Inc. is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions. Its primary function lies in advancing novel drug candidates aimed at addressing unmet medical needs within the healthcare sector. The company emphasizes research and development, with a focus on diseases that currently lack effective treatment options, potentially impacting various medical fields such as oncology, neurology, and autoimmune disorders. Continua Therapeutics Inc. is significant in the market due to its commitment to pioneering next-generation pharmaceuticals that could redefine standard treatment protocols. Through strategic collaborations and a robust pipeline of research projects, the company plays a critical role in the biotech industry, pushing the boundaries of medical science.

About

CEO
Mr. Carmine N. Stengone MBA, MS
Employees
41
Address
3565 General Atomics Court
Suite 200
San Diego, 92121, CA
United States
Phone
858 333 5280
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Pre-market

Exchange is currently open for pre-market.
Main market opens in 17 minutes

09:12
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).